ALHC — Alignment Healthcare Inc. price, chart and key statistics

Price data

Price

$8.51

YTD price return

-56.91%

YTD total return

-56.91%

Next earnings

Oct 29, 2026 · After close

Market cap

1.8B2021-03 4.1B2026-10 1.8B-57.0% over the window

Enterprise value

1.4B

Shares outstanding

207.4M2020-12 164.1M2026-06 207.4M+26.4% over the window

52W low

$6.01

52W high

$25.12

From 52W high

-66.12%

From 52W low

+41.60%

52W range

13%

Volume

Rel volume

0.29×

30D volume

11.8M

30D $ vol

101.8M

Fundamentals

Sales (ttm)

4.6B2019-12 754M2026-06 4.6B+507.1% over the window

Sales/share

$22.072020-12 $5.822026-06 $22.07+278.9% over the window

EPS (ttm)

$0.202020-12 -$0.152026-06 $0.20-235.0% over the window

FCF (ttm)

177.5M2022-12 -69.2M2026-06 177.5M-356.5% over the window

FCF/share

$0.862022-12 -$0.372026-06 $0.86-331.6% over the window

Book value/share

$1.282020-06 $0.312026-06 $1.28+312.3% over the window

Net margin

0.89%2019-12 -5.9%2026-06 0.9%-115.0% over the window

ROE

15.35%2020-12 -74.9%2026-06 15.4%-120.5% over the window

ROA

3.18%2020-12 -6.8%2026-06 3.2%-147.0% over the window

Debt / equity

1.22×2020-12 4.712026-06 1.22-74.0% over the window

Current ratio

1.702020-12 1.722026-06 1.70-1.6% over the window

Growth (CAGR, ttm) · 10Y

Sales

+37.24%2025-06-30 → 2026-06-303.3B → 4.6B (+37.2% total)+41.60%2023-06-30 → 2026-06-301.6B → 4.6B (+184.0% total)+33.92%2021-06-30 → 2026-06-301.1B → 4.6B (+330.6% total)n/a

FCF

+525.70%2025-06-30 → 2026-06-3028.4M → 177.5M (+524.9% total)n/an/an/a

Shares

+4.75%2025-06-30 → 2026-06-30198M → 207.4M (+4.7% total)+3.26%2023-06-30 → 2026-06-30188.4M → 207.4M (+10.1% total)+2.07%2021-06-30 → 2026-06-30187.3M → 207.4M (+10.8% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+31.02%2025-06-30 → 2026-06-30$16.85 → $22.07 (+31.0% total)+37.13%2023-06-30 → 2026-06-30$8.55 → $22.07 (+157.9% total)+31.21%2021-06-30 → 2026-06-30$5.68 → $22.07 (+288.8% total)n/a

FCF/share

+497.32%2025-06-30 → 2026-06-30$0.14 → $0.86 (+496.6% total)n/an/an/a

Book value/share

+79.63%2025-06-30 → 2026-06-30$0.71 → $1.28 (+79.6% total)+4.67%2023-06-30 → 2026-06-30$1.11 → $1.28 (+14.7% total)-6.80%2021-06-30 → 2026-06-30$1.82 → $1.28 (-29.7% total)n/a

Price

-51.09%2025-10-20 → 2026-10-20$17.39 → $8.51 (-51.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+6.22%2023-10-20 → 2026-10-20$7.10 → $8.51 (+19.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-15.06%2021-10-20 → 2026-10-20$19.25 → $8.51 (-55.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

-51.09%2025-10-20 → 2026-10-20$17.39 → $8.51 (-51.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+6.22%2023-10-20 → 2026-10-20$7.10 → $8.51 (+19.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-15.06%2021-10-20 → 2026-10-20$19.25 → $8.51 (-55.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

42.0×2021-03 -58.902026-10 43.37-173.6% over the window

Fwd P/E

13.1×

P/S (ttm)Market cap ÷ TTM revenue.

0.4×2021-03 4.112026-10 0.39-90.6% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

6.7×2021-03 11.592026-10 6.66-42.6% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

9.9×2023-03 -17.312026-10 9.94-157.4% over the window

EV/EBITDA (fy)

16.1×

EV/Sales (ttm)

0.3×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

10.06%2022-12 -3.1%2026-06 3.6%-214.4% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 207.4M ÷ 198.0M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-4.75%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-4.75%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($2.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-4.75%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2020-12 -3.3%2026-06 0.0%-100.0% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.8B). Same caveat as the cash buyback yield.

0.00%2020-12 -3.3%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/S

2nd

P/B

20th